Review of Octreotide Use for End-of-Life Symptom Management by Indication in an Inpatient Hospice Setting

Presenter/Author Information

Lisa PetersonFollow
Kavita Sharma, Advocate Aurora HealthFollow
Sarah Riutta, Advocate Aurora HealthFollow

Recommended Citation

Peterson L, Sharma K, Ruitta S. Review of Octreotide Use for End-of-Life Symptom Management by Indication in an Inpatient Hospice Setting. J Patient Cent Res Rev. 2023;10:265-66. doi: 10.17294/2330-0698.2070

Affiliations

Aurora St. Luke’s Medical Center, Aurora UW Medical Group, Aurora Sinai Medical Center

Presentation Notes

Poster presented at: Advocate Aurora Health Scientific Day; May 24, 2023; virtual webinar hosted in Milwaukee, WI. https://institutionalrepository.aah.org/sciday/2023/general/8/

Full Text of Presentation

wf_no

Document Type

Abstract